Immucell (ICCC) Research & Development (2010 - 2026)
Immucell's Research & Development was $119,652 in Q2 2026, down 85.6% from $831,858 a year earlier.
Powered by 
Analysis
Immucell (ICCC) Research & Development (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Immucell's Research & Development was $2.4 million through Jun 30, 2026, down 24.7% year-over-year; for FY2025, it was $3.04 million, down 22.0% from FY2024.
- Research & Development has now declined for three consecutive years, with a five-year compound annual growth rate of -6.9% (FY2020 to FY2025).
- In earlier years, Research & Development was $3.9 million in FY2024 (-11.3%), $4.39 million in FY2023 (-2.2%), $4.49 million in FY2022 (+7.8%) and $4.17 million in FY2021 (-4.3%).
- The Q2 2026 figure marks the lowest quarterly Research & Development in data going back to Q2 2010.
- The best year-over-year quarter for Research & Development over five years was Q3 2022 (growth of 21.2%); the worst was Q2 2026 (a decline of 85.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Immucell | 95.91 Mn | 73.35 Mn | 2.44 Mn | 119,652.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 119,652.00 |
| Dec 31, 2025 | 758,864.00 |
| Sep 30, 2025 | 694,311.00 |
| Jun 30, 2025 | 831,858.00 |
| Mar 31, 2025 | 756,847.00 |
| Dec 31, 2024 | 819,393.00 |
| Sep 30, 2024 | 786,136.00 |
| Jun 30, 2024 | 1.03 Mn |
| Mar 31, 2024 | 1.26 Mn |
| Sep 30, 2023 | 1.12 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | 1.11 Mn |
| Dec 31, 2022 | 1.05 Mn |
| Sep 30, 2022 | 1.27 Mn |
| Jun 30, 2022 | 1.14 Mn |
| Mar 31, 2022 | 1.04 Mn |
| Dec 31, 2021 | 1.09 Mn |
| Sep 30, 2021 | 1.05 Mn |
| Jun 30, 2021 | 1.00 Mn |
| Mar 31, 2021 | 1.03 Mn |
API Access
Immucell Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ICCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();